Pelthos Therapeutics Inc. (AMEX: PTHS) last traded at $25.51, down 4.31% on the session. The quote above updates while this page is open; the figures below are drawn from Pelthos Therapeutics Inc.’s own filings and are restated only when a new one is published.
Pelthos Therapeutics Inc. trades on AMEX under the ticker PTHS. Its market capitalisation is $97.66 million.
Valuation measures for Pelthos Therapeutics Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $97.66M |
|---|---|
| Enterprise value | $212.33M |
| Price / sales | 2.26 |
| Beta | 0.51 |
Trailing-twelve-month figures tagged in Pelthos Therapeutics Inc.'s XBRL filings with the SEC.
| Revenue (TTM) | $43.30M |
|---|---|
| Net income (TTM) | -$86.39M |
| EPS (TTM) | -$28.73 |
| Operating margin | -133.42% |
| Cash | $24.19M |
Range and volume for PTHS over the past 52 weeks.
| 52-week high | $37.50 |
|---|---|
| 52-week low | $18.19 |
| Volume | 20.8K |
| Average volume | 48.9K |
| Previous close | $26.66 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.